THERAPEUTICS
Wasna’s approach to better blood
State of the industry
Blood plasma is essential for cell culture due to its growth factors and proteins, but human sources encounter issues like supply shortages, ethical concerns, and significant batch variability. This inconsistency affects the reliability of research and therapeutic development, challenging standardization and reproducibility in biomedical applications.
Why Wasna?
Wasna's patent pending human serum is the only solution that provides a cost-effective and full-spectrum serum alternative without relying on donor-sourced blood components.
-
Xeno-Free Origin
Developed from a human cell line, our serum alternative eliminates the use of animal-derived components.
-
Reduced Variation
Our clonal cell technology ensures consistent batch quality, supporting reliable research outcomes.
-
Enhanced Safety
Our process eliminates the risk of contamination from pathogens, providing a safer option for cell cultures.
-
High Performance
Proven effective across various industrial cell lines such as HeLa, MCF7, HEK293, and HepG2, our serum supports robust cell growth.
